333

P&K SKIN RESEARCH CENTER

No trades
See on Supercharts
Market capitalization
‪85.85 B‬KRW
‪4.81 B‬KRW
‪14.84 B‬KRW
‪12.10 M‬
Beta (1Y)
0.78

About P&K SKIN RESEARCH CENTER

Headquarters
Seoul
Employees (FY)
99
Founded
2010
ISIN
KR7347740003
FIGI
BBG00W1M0RG2
P&K Skin Research Center Co. Ltd. engages in the examination and assessment of cosmetics and skincare products. It operates through the following business areas: human body application test, safety assessment, cosmetic efficacy effect assessment, functional cosmetics assessment, sensitivity assessment, and in vitro test. The company was founded on October 7, 2010 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 347740 is 2885 KRW — it has decreased by 1.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange P&K SKIN RESEARCH CENTER stocks are traded under the ticker 347740.
347740 stock is 1.74% volatile and has beta coefficient of 0.78. Check out the list of the most volatile stocks — is P&K SKIN RESEARCH CENTER there?
Yes, you can track P&K SKIN RESEARCH CENTER financials in yearly and quarterly reports right on TradingView.
347740 stock has risen by 3.59% compared to the previous week, the month change is a 3.03% fall, over the last year P&K SKIN RESEARCH CENTER has showed a 7.38% decrease.
347740 net income for the last quarter is ‪2.03 B‬ KRW, while the quarter before that showed ‪929.86 M‬ KRW of net income which accounts for 118.47% change. Track more P&K SKIN RESEARCH CENTER financial stats to get the full picture.
Today P&K SKIN RESEARCH CENTER has the market capitalization of ‪85.43 B‬, it has increased by 3.61% over the last week.
Yes, 347740 dividends are paid annually. The last dividend per share was 30.00 KRW. As of today, Dividend Yield (TTM)% is 1.05%. Tracking P&K SKIN RESEARCH CENTER dividends might help you take more informed decisions.
P&K SKIN RESEARCH CENTER dividend yield was 1.22% in 2023, and payout ratio reached 18.69%. The year before the numbers were 1.15% and 14.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 347740 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade P&K SKIN RESEARCH CENTER stock right from TradingView charts — choose your broker and connect to your account.
347740 reached its all-time high on Jul 27, 2022 with the price of 8340 KRW, and its all-time low was 2225 KRW and was reached on Oct 31, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 99.00 employees. See our rating of the largest employees — is P&K SKIN RESEARCH CENTER on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So P&K SKIN RESEARCH CENTER technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating P&K SKIN RESEARCH CENTER stock shows the neutral signal. See more of P&K SKIN RESEARCH CENTER technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. P&K SKIN RESEARCH CENTER EBITDA is ‪3.11 B‬ KRW, and current EBITDA margin is 20.98%. See more stats in P&K SKIN RESEARCH CENTER financial statements.